Related Experiment Video
Updated: May 31, 2026

Direct and Indirect Culture Methods for Studying Biodegradable Implant Materials In Vitro
Published on: April 15, 2022
Current progress in inorganic artificial biomaterials
Zhixia Li1, Masakazu Kawashita
1Graduate School of Biomedical Engineering, Tohoku University, 6-6-11-901-4 Aramaki-Aoba, Aoba-ku, Sendai, Japan. zhixia@ecei.tohoku.ac.jp
This review summarizes recent developments in inorganic artificial biomaterials, including bioceramics, metallic alloys, and composites. The focus is on how these materials can be improved for medical applications such as implants and cancer treatments. Researchers are exploring ways to enhance biocompatibility, mechanical strength, and functionality through surface modifications and composite structures. While promising materials like porous calcium phosphate ceramics and titanium alloys show potential, more research is needed to understand their long-term effects in the human body.
Area of Science:
- Biomaterials in regenerative medicine
- Medical device development in orthopedics
- Advanced ceramic and metallic material science
Background:
Prior research has shown that traditional biomaterials face limitations in mechanical compatibility and biological integration. Established knowledge includes the use of titanium alloys in orthopedic implants due to their mechanical reliability. This gap motivated investigations into new material compositions and surface modifications. That uncertainty drove the exploration of biodegradable composites and porous structures for tissue engineering. No prior work had resolved the long-term biological response to inorganic implants in complex physiological environments. Researchers have proposed calcium phosphate ceramics as promising scaffolds due to their bone-like properties. It was already known that surface treatments can influence apatite formation on metallic implants. This paper contributes by reviewing recent innovations in bioceramics, metallic alloys, and composite materials for medical applications.
Purpose Of The Study:
The aim of this review is to synthesize recent developments in inorganic artificial biomaterials. The specific problem addressed is the need to improve biocompatibility and mechanical performance of implants. The motivation stems from the limitations of current materials in terms of degradation and integration. This paper focuses on evaluating new materials and surface treatments for medical applications. The authors propose that bioceramics and metallic alloys represent viable alternatives to traditional implants. The study also considers the potential of composite materials to enhance functionality and reduce invasiveness. A key objective is to assess the progress in developing materials for minimally invasive cancer therapies. The authors aim to highlight the challenges in translating these materials into clinical use.
Main Methods:
The review approach includes a comprehensive analysis of recent literature on inorganic biomaterials. The authors synthesized findings from studies on calcium phosphate ceramics, titanium alloys, and composites. They examined the effects of adding biodegradable polymers to ceramic scaffolds. The study also evaluated the impact of physical surface treatments on titanium alloys. The authors analyzed the role of chemical bonding methods in improving blood compatibility of implants. They considered the potential of Ni-free and Co-Cr-Mo alloys for medical applications. The review also assessed the use of glass microspheres and ferrimagnetic particles in cancer treatment. The authors synthesized evidence to identify gaps in biological response data for these materials.
Main Results:
Porous calcium phosphate ceramics have shown potential as scaffolds due to their bone ingrowth properties. The addition of biodegradable polymers has modified the degradability and mechanical behavior of these ceramics. Titanium alloys remain a reliable choice for orthopedic implants due to their mechanical performance. Surface treatments like grooving have improved apatite formation on titanium alloy implants. Blood-compatible polymers like poly(ethylene glycol) have been successfully bonded to titanium surfaces. Ni-free and Co-Cr-Mo alloys have demonstrated new functional properties for medical use. Glass microspheres and ferrimagnetic particles have shown potential for minimally invasive cancer therapies. However, the biological response to these materials remains a major challenge before clinical application.
Conclusions:
The authors synthesize that inorganic biomaterials are advancing in terms of functionality and application. They propose that porous ceramics and biodegradable composites are promising for tissue engineering. The review highlights that titanium alloys remain a standard in orthopedic and dental implants. Surface modifications have been shown to enhance the biological performance of metallic implants. The authors suggest that chemical bonding of blood-compatible polymers improves implant safety. New alloys like Ni-free and Co-Cr-Mo are being explored for enhanced medical performance. Glass microspheres and ferrimagnetic particles offer potential for non-surgical cancer treatment. The authors emphasize the need for further research on the biological interactions of these materials.
Frequently Asked Questions
Recent studies suggest that porous calcium phosphate ceramics may support bone ingrowth, making them suitable for tissue engineering.
Adding polymers like chitosan or collagen modifies the degradability and mechanical properties of ceramics.
Surface treatments like grooving improve apatite formation on titanium alloys, which may enhance bone integration.
PEG can be chemically bonded to titanium surfaces to improve blood compatibility, as shown in recent studies.
These particles may enable minimally invasive cancer treatments through hyperthermia or in situ radiotherapy.
The biological response between artificial implants and the human body remains a major challenge before clinical use.

